Old Web
English
Sign In
Acemap
>
Paper
>
FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe
FaMRIsc trial shows: MRI breast screening for women with ≥20% lifetime risk is also cost-effective in Europe
2021
Madeleine M.A. Tilanus-Linthorst
A. Geuzinge
Inge-Marie Obdeijn
E.J.T. Rutgers
Roger H. Mann
S Saadatmand
D.B.W. de Roy van Zuidewijn
Jan C. Oosterwijk
R.A.E.M. Tollenaar
M.G.E.M. Ausems
M. van’t Riet
S.V. Margrethe
Maartje J. Hooning
Jelle Wesseling
K Kristine
Ernest J.T. Luiten
C. Verhoef
Eveline A.M. Heijnsdijk
H.J. de Koning
Keywords:
Obstetrics
Medicine
lifetime risk
MRI breast
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]